These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 171464)

  • 1. Interaction in culture between mouse ascites hepatoma (MH-134) cells and lymphoid cells of isologous mice.
    Katsuta H; Ashikawa K; Takaoka T
    Jpn J Exp Med; 1975 Aug; 45(4):269-84. PubMed ID: 171464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction in culture between mouse ascites mammary carcinoma (MM2) cells and lymphoid cells of isologous mice.
    Katsuta H; Ashikawa K; Takaoka T
    Jpn J Exp Med; 1975 Jun; 45(3):223-9. PubMed ID: 1177362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage migration inhibition-activity after implantation of methylcholanthrene-induced sarcoma, Ehrlich ascites cancer or mouse ascites hepatoma-134 cancer cells in mice.
    Yumura M
    Acta Med Okayama; 1976 Feb; 30(1):37-48. PubMed ID: 184687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-lapse changes in the concomitant immunity of lymphocytes from different sites of mice isografted with methylcholanthrene-induced tumor.
    Orita K; Ohnishi N; Matuso Y; Konaga E; Kokumai Y
    Acta Med Okayama; 1975 Apr; 29(2):85-91. PubMed ID: 126005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-specific immune responsiveness of the tumor-bearing host.
    Burk MW; Yu S; McKhann CF
    Isr J Med Sci; 1976; 12(4-5):360-8. PubMed ID: 939694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melphalan-induced enhancement of antitumor immune reactivity in thymocytes of adult BALB/c mice bearing a large MOPC-315 tumor.
    Bartik MM; Takesue BY; Mokyr MB
    Cancer Res; 1987 Sep; 47(18):4848-55. PubMed ID: 3497711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of the cells proliferating in parent versus F hybrid mixed lymphocyte culture.
    Piguet PF; Dewey HK; Vassalli P
    J Exp Med; 1975 Apr; 141(4):775-87. PubMed ID: 1092790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of in vitro cell-mediated reactivity against syngeneic tumor cells by various lymphoid cell populations from Bacillus Calmette-Guérin-tumor-cured, tumor-sensitized, tumor-bearing, and normal inbred guinea pigs.
    Fidler IJ; Kataoka T; Hanna MG
    Cancer Res; 1976 Dec; 36(12):4459-66. PubMed ID: 187324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression by tumor growth of T cell growth factor production in mouse lymphoid cell cultures.
    Kedar E; Katz-Gross A; Chriqui-Zeira E; Bercowitz H
    J Biol Response Mod; 1984 Oct; 3(5):547-60. PubMed ID: 6334140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on tissue culture of ascites tumors II. In vitro growth of mouse ascites hepatoma MH 134.
    Goto M; Sato H
    Sci Rep Res Inst Tohoku Univ Med; 1965 Dec; 12(3):312-8. PubMed ID: 4287223
    [No Abstract]   [Full Text] [Related]  

  • 11. Production of colony-stimulating factor by tumor cells and the factor-mediated induction of suppressor cells.
    Tsuchiya Y; Igarashi M; Suzuki R; Kumagai K
    J Immunol; 1988 Jul; 141(2):699-708. PubMed ID: 2968407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bryostatin 1/ionomycin (B/I) ex vivo stimulation preferentially activates L-selectinlow tumor-sensitized lymphocytes.
    Chin CS; Miller CH; Graham L; Parviz M; Zacur S; Patel B; Duong A; Bear HD
    Int Immunol; 2004 Sep; 16(9):1283-94. PubMed ID: 15262898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation from tumor-bearing mice of lymphocytes with in vivo therapeutic efficacy.
    Shu SY; Chou T; Rosenberg SA
    J Immunol; 1987 Jul; 139(1):295-304. PubMed ID: 2953816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T and B lymphocyte migration into syngeneic tumors.
    Elboim CM; Reinisch CL; Schlossman SF
    J Immunol; 1977 Mar; 118(3):1042-8. PubMed ID: 300384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In situ lymphoid cells of mouse mammary tumors. IV. Comparison of functional activity of lymphoid cells separated from mammary tumors to that of spleen and lymph node cells of tumor-sensitized mice.
    Ruppert B; Blazar B; Medina D; Heppner G
    J Immunol; 1979 Jun; 122(6):2180-3. PubMed ID: 448122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic inhibitory activity of regional lymph node cells in the mouse isografted with methylcholanthrene-induced tumor.
    Orita K; Onishi N; Kunisada K; Konaga E; Kokumai Y
    Acta Med Okayama; 1975 Jun; 29(3):183-7. PubMed ID: 127512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of normal T lymphocytes in tumor-bearing rats.
    Klobusická M; Koníková E
    Neoplasma; 1982; 29(6):727-34. PubMed ID: 6984490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in the responsiveness of splenic, lymph node, and peripheral blood lymphoid cells to tumor membrane extracts.
    Krueger JG; Segal RA; Moyer RC
    Cancer Res; 1977 Jan; 37(1):320-2. PubMed ID: 830419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the host lymphocyte subsets during chemical carcinogenesis.
    Brodt P; Lala PK
    Cancer Res; 1983 Sep; 43(9):4315-22. PubMed ID: 6871866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentation of antitumor immune response by trinitrophenyl (TNP)-reactive helper T-cells: enhanced induction of tumor-specific Lyt-1+2- T-cell-mediated delayed-type hypersensitivity from spleen cells of tumor-bearing mice by TNP helpers.
    Suda T; Fujiwara H; Mizushima Y; Shearer GM; Hamaoka T
    J Natl Cancer Inst; 1986 Dec; 77(6):1267-72. PubMed ID: 2948049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.